N-Nitroso Oxetacaine Stage D | N-methyl-N-(2-methyl-1-phenylpropan-2-yl)nitrous amide
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.N-Nitroso Oxetacaine Stage D can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Nitrosamines .N-Nitroso Oxetacaine Stage D is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Oxetacaine Stage D CAS NO: NA Chemically represented as N-methyl-N-(2-methyl-1-phenylpropan-2-yl)nitrous amide.Synchemia is the leading manufacturing and exporter of N-Nitroso Oxetacaine Stage D .We supply N-Nitroso Oxetacaine Stage D with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143619 |
| CAS No | NA |
| Mol.F. | C17H21D3N4O3 |
| Mol.Wt. | 335.4 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143620 |
| CAS No | NA |
| Mol.F. | C13H10D2N4O |
| Mol.Wt. | 242.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143621 |
| CAS No | NA |
| Mol.F. | C13H8D4N4O |
| Mol.Wt. | 244.3 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143622 |
| CAS No | NA |
| Mol.F. | C18H17D4N3OS |
| Mol.Wt. | 331.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143623 |
| CAS No | NA |
| Mol.F. | C18H13D8N3OS |
| Mol.Wt. | 335.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143624 |
| CAS No | NA |
| Mol.F. | C17H12D3FN4O3S |
| Mol.Wt. | 377.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143625 |
| CAS No | NA |
| Mol.F. | C17H11D4FN4O3S |
| Mol.Wt. | 378.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143626 |
| CAS No | NA |
| Mol.F. | C14H13D8N3O4 |
| Mol.Wt. | 303.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143627 |
| CAS No | 1330180-56-7 |
| Mol.F. | C4HD8N3O |
| Mol.Wt. | 123.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143628 |
| CAS No | NA |
| Mol.F. | C25H23D3N2O2 |
| Mol.Wt. | 389.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143629 |
| CAS No | NA |
| Mol.F. | C10H9ClN2O |
| Mol.Wt. | 208.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143630 |
| CAS No | NA |
| Mol.F. | C22H35N3O6S |
| Mol.Wt. | 469.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143631 |
| CAS No | NA |
| Mol.F. | C15H19D3N2O3 |
| Mol.Wt. | 281.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143632 |
| CAS No | NA |
| Mol.F. | C14H16N6O |
| Mol.Wt. | 284.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143633 |
| CAS No | NA |
| Mol.F. | C17H18F3N7O2 |
| Mol.Wt. | 409.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143634 |
| CAS No | NA |
| Mol.F. | C5H7D5N2O |
| Mol.Wt. | 121.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |